Status:

COMPLETED

Factors Affecting Early Progress of Cochlear Implant Outcomes in Adults

Lead Sponsor:

Cochlear

Collaborating Sponsors:

EVAMED

Conditions:

Sensorineural Hearing Loss, Bilateral

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.

Eligibility Criteria

Inclusion

  • Adult subjects, 18 years or older
  • Subjects unilaterally implanted or bilaterally implanted with at least 6 months separating the two cochlear implantations.
  • Subjects who have been implanted between January 2016 and December 2021.
  • Subjects have received a Nucleus CI: CI512, CI522 or CI532 cochlear implants with non-rotating magnet, or CI600 series equivalent CI612, CI622 and CI632 with rotating magnet and external sound processors CP900 or CP1000 behind-the-ear, or Kanso or Kanso 2 off-the-ear types.
  • Subjects who are fluent in French (language used in the questionnaire and speech tests)
  • Subjects who are not opposed to participating in the study
  • Subjects for who the medical record data is available throughout the defined data search period.

Exclusion

  • Subjects with single-sided deafness (SSD).
  • Subjects who are not affiliated to the French Social Security.
  • Subjects who are under legal protection.

Key Trial Info

Start Date :

April 21 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 20 2022

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT05265260

Start Date

April 21 2022

End Date

September 20 2022

Last Update

April 5 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Pierre-Paul Riquet, ORL, otoneurologie et ORL pédiatrique

Toulouse, France, 31059